Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.58 USD | +0.39% | +4.67% | +11.21% |
May. 09 | Transcript : Mersana Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
May. 09 | Earnings Flash (MRSN) MERSANA THERAPEUTICS Posts Q1 Revenue $9.2M, vs. Street Est of $8.5M | MT |
Financials (USD)
Sales 2024 * | 35.91M | Sales 2025 * | 33.12M | Capitalization | 316M |
---|---|---|---|---|---|
Net income 2024 * | -84M | Net income 2025 * | -99M | EV / Sales 2024 * | 6.23 x |
Net cash position 2024 * | 91.88M | Net cash position 2025 * | 44.36M | EV / Sales 2025 * | 8.19 x |
P/E ratio 2024 * |
-3.84
x | P/E ratio 2025 * |
-3.53
x | Employees | 123 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.3% |
Latest transcript on Mersana Therapeutics, Inc.
1 day | +0.39% | ||
1 week | +4.67% | ||
Current month | -18.61% | ||
1 month | -31.38% | ||
3 months | -32.11% | ||
6 months | +67.53% | ||
Current year | +11.21% |
Managers | Title | Age | Since |
---|---|---|---|
Martin Huber
CEO | Chief Executive Officer | 64 | 20-04-12 |
Director of Finance/CFO | 46 | 19-07-09 | |
David Mott
CHM | Chairman | 58 | 12-07-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Kristen Hege
BRD | Director/Board Member | 60 | 16-07-31 |
David Mott
CHM | Chairman | 58 | 12-07-30 |
Anna Protopapas
BRD | Director/Board Member | 59 | 15-03-01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.05% | 0 M€ | 0.00% | - | |
0.04% | 0 M€ | 0.00% | - | |
0.03% | 234 M€ | +6.34% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 2.58 | +0.39% | 1,278,493 |
24-05-15 | 2.57 | -1.53% | 1,891,617 |
24-05-14 | 2.61 | -0.38% | 5,346,704 |
24-05-13 | 2.62 | -3.32% | 2,238,898 |
24-05-10 | 2.71 | +9.94% | 2,807,159 |
Delayed Quote Nasdaq, May 16, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.21% | 314M | |
+8.29% | 113B | |
+10.21% | 106B | |
+0.41% | 22.27B | |
-11.90% | 22.22B | |
-5.99% | 19.43B | |
-37.36% | 17.87B | |
-5.17% | 17.24B | |
+7.70% | 14.29B | |
+37.65% | 12.52B |
- Stock Market
- Equities
- MRSN Stock